EXANE DERIVATIVES - IGM BIOSCIENCES INC ownership

IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 92 filers reported holding IGM BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of IGM BIOSCIENCES INC
ValueSharesWeighting
Q2 2022$865,000
-32.6%
480.0%0.00%
Q1 2022$1,283,000
-8.9%
480.0%0.00%
Q4 2021$1,408,000
-55.4%
480.0%0.00%
-100.0%
Q3 2021$3,156,000
-21.2%
480.0%0.00%0.0%
Q2 2021$4,006,000
-93.7%
48
-94.2%
0.00%
-94.4%
Q1 2021$63,880,000
-61.3%
833
-55.5%
0.02%
-63.3%
Q4 2020$165,095,000
+19.6%
1,8700.0%0.05%
+22.5%
Q3 2020$138,017,000
-3.1%
1,870
-4.2%
0.04%
+5.3%
Q2 2020$142,486,000
+55.7%
1,952
+19.8%
0.04%
+46.2%
Q1 2020$91,520,0001,6300.03%
Other shareholders
IGM BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 3,425,455$225,258,0003.93%
Artal Group S.A. 1,350,000$88,776,0001.99%
Eagle Bay Advisors LLC 35,295$2,321,0001.30%
Cormorant Asset Management, LP 350,000$23,016,0000.94%
Baker Brothers Advisors 3,156,102$207,545,0000.91%
Bruce & Co., Inc. 55,000$3,616,0000.77%
Altium Capital Management LP 42,473$2,793,0000.73%
HighVista Strategies LLC 15,446$1,016,0000.67%
Woodline Partners LP 569,009$37,418,0000.61%
Ikarian Capital, LLC 100,000$6,576,0000.46%
View complete list of IGM BIOSCIENCES INC shareholders